NIH-funded research R15 grant

Understanding how Fbxo16 controls neuron development

Official title: Protein Degradation Pathways in Neurogenesis: The Critical Role of Fbox E3 ligases

Funded at Georgetown University · NIH-11359949 · Data updated 2026-11-12

Researchers are studying how a neural protein, Fbxo16, helps nerve cells form and mature, using a frog embryo model to uncover its role in autism-related brain development.

Quick facts

Grant typeR15 grant
Study typeNIH-funded research
Funding institutionGeorgetown University
NIH-funded
Lab location1 site (Washington, United States)
Project startMay 20, 2026
Project endApril 30, 2029
Funding year2026
Award (this year)$585,000
NIH project number1R15NS145029-01A1
Project IDNIH-11359949 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are individuals with autism spectrum disorder or related neurodevelopmental conditions, whose caregivers may seek information about underlying brain development mechanisms and future trial opportunities.

Less likely to help

This basic research does not involve direct patient treatment and may not benefit individuals seeking immediate clinical therapies.

What this research studies

This project looks at Fbxo16, a brain-specific protein, to see how it influences when and how neurons form during early brain development. Using Xenopus laevis embryos, the team will tweak Fbxo16 levels in neural tissue and observe effects on a key neural factor, Neurog2, including whether altered Fbxo16 changes neuron numbers through cell growth or death. They will also identify which proteins Fbxo16 targets and how those targets affect neuron formation. The work aims to reveal mechanisms that could be relevant to autism by connecting protein degradation pathways to neural development processes.

Why it matters

Potential benefit: If successful, the findings could clarify molecular pathways involved in autism and point toward new ideas for therapies that support proper neuron formation.

How similar studies have gone: Similar studies in model organisms have helped map how protein degradation impacts neural development, supporting the potential relevance of Fbxo16 pathways.

Where this research is happening

  • Georgetown University
    Washington, United States
    Active

Researchers

  • Principal investigator: Silva, Elena M — Georgetown University
  • Study coordinator: Silva, Elena M

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.